// App-Quantinova.ai

18643 : Role for RUNX2 in Pulmonary Arterial Hypertension

Researchers

Presenter

  • Sophie Chabot

Principal Investigators

  • Sandra Breuils-Bonnet

  • Pasquale Ferraro

  • Steeve Provencher

  • Sebastien Bonnet

Medical Centers

  • Montreal, Canada

  • Laval University, Quebec, Quebec, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • B-cell lymphoma 2

  • Proliferation marker protein Ki-67

  • Signal transducer and activator of transcription 3

  • Bone Morphogenetic Protein Receptor Type 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved